BioWorld

July 26, 2001

View Archived Issues

Correction

Read More

OSI, Genentech Start Phase III Program Of Tarceva In Cancer

Read More

Other News To Note

Read More

Synthetic Antibiotics Nature Never Saw Work Well In Mice With Hope For Long-Stalled Drug Resistance

Read More

ViaCell Acquires Cerebrotec, Forms Neuroscience Division

Read More

Medarex, HGS Sign UltiMAb Deal For Undisclosed Areas

Read More

Amylin Faces Uphill Fight; Aviron Poised For Approval

Read More